<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CRE</journal-id>
<journal-id journal-id-type="hwp">spcre</journal-id>
<journal-id journal-id-type="nlm-ta">Clin Rehabil</journal-id>
<journal-title>Clinical Rehabilitation</journal-title>
<issn pub-type="ppub">0269-2155</issn>
<issn pub-type="epub">1477-0873</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0269215512448256</article-id>
<article-id pub-id-type="publisher-id">10.1177_0269215512448256</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Evaluative studies</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Aquatic exercise in a chest-high pool for hormone therapy-induced arthralgia in breast cancer survivors: a pragmatic controlled trial</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Cantarero-Villanueva</surname><given-names>I</given-names></name>
<xref ref-type="aff" rid="aff1-0269215512448256">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Fernández-Lao</surname><given-names>C</given-names></name>
<xref ref-type="aff" rid="aff1-0269215512448256">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Caro-Morán</surname><given-names>E</given-names></name>
<xref ref-type="aff" rid="aff1-0269215512448256">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Morillas-Ruiz</surname><given-names>J</given-names></name>
<xref ref-type="aff" rid="aff2-0269215512448256">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Galiano-Castillo</surname><given-names>N</given-names></name>
<xref ref-type="aff" rid="aff1-0269215512448256">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Díaz-Rodríguez</surname><given-names>L</given-names></name>
<xref ref-type="aff" rid="aff2-0269215512448256">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Arroyo-Morales</surname><given-names>M</given-names></name>
<xref ref-type="aff" rid="aff1-0269215512448256">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0269215512448256"><label>1</label>Physical Therapy Department, Faculty of Health Sciences, University of Granada, Spain</aff>
<aff id="aff2-0269215512448256"><label>2</label>Nursing Department, Faculty of Health Sciences, University of Granada, Spain</aff>
<author-notes>
<corresp id="corresp1-0269215512448256">Manuel Arroyo Morales, Physical Therapy Department, Faculty of Health Sciences, Avda. Madrid s/n, 18071 Granada, Spain. Email: <email>marroyo@ugr.es</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2013</year>
</pub-date>
<volume>27</volume>
<issue>2</issue>
<fpage>123</fpage>
<lpage>132</lpage>
<history>
<date date-type="received">
<day>30</day>
<month>1</month>
<year>2012</year></date>
<date date-type="accepted">
<day>21</day>
<month>4</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec id="section1-0269215512448256">
<title>Objective:</title>
<p>To investigate the impact of aquatic exercise on pressure pain threshold in breast cancer survivors with hormone therapy-associated arthralgia.</p>
</sec>
<sec id="section2-0269215512448256">
<title>Design:</title>
<p>Single-blind, controlled trial.</p>
</sec>
<sec id="section3-0269215512448256">
<title>Setting:</title>
<p>Two major metropolitan hospitals and a Sport and Spa Club in Granada, Spain.</p>
</sec>
<sec id="section4-0269215512448256">
<title>Subjects:</title>
<p>Forty women aged 29–71 years with stage I–III breast cancer who reported arthralgia.</p>
</sec>
<sec id="section5-0269215512448256">
<title>Intervention:</title>
<p>Patients were allocated alternately to either aquatic exercise in a chest-high pool or usual care while on the waiting list; control patients received treatment later. The two-month hydrotherapy intervention consisted of 24 sessions 3 days per week. Each session included 5 minutes of warm-up, 15–20 minutes of aerobic exercise, 15 minutes of mobility exercise and 20 minutes of recovery techniques.</p>
</sec>
<sec id="section6-0269215512448256">
<title>Main measures:</title>
<p>Pressure pain threshold at neck, shoulder, hand and leg were evaluated as primary outcomes. Cancer-related fatigue, as measured by the Piper Fatigue Scale, body mass index and waist circumference were secondary outcomes. A 2 × 2 repeated-measure ANCOVA was used in this study.</p>
</sec>
<sec id="section7-0269215512448256">
<title>Results:</title>
<p>No adverse events or development of worsening of pain was observed. Almost all the participants in the intervention group (89%) adhered to the hydrotherapy programme. Participants experienced a decrease in pressure pain threshold measured in neck, hand, shoulder and leg, as measured by algometry pressure, and waist circumference; all <italic>P</italic> &lt; 0.05. Cancer-related fatigue (<italic>P</italic> = 0.06) and body mass index (<italic>P</italic> = 0.42) did not show significant improvement.</p>
</sec>
<sec id="section8-0269215512448256">
<title>Conclusions:</title>
<p>These data suggest that hydrotherapy in a chest-high pool may reduce the pain threshold and waist circumference in breast cancer survivors with hormone therapy-associated arthralgia.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Cancer</kwd>
<kwd>exercise</kwd>
<kwd>fatigue</kwd>
<kwd>hydrotherapy</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section9-0269215512448256" sec-type="intro">
<title>Introduction</title>
<p>Hormone therapy for carcinoma of the breast may be associated with debilitating arthralgia in a small proportion of users. The actual incidence of arthralgias or musculoskeletal symptoms in breast cancer survivors using hormone therapy is not known, though such symptoms have been reported to be between 5% and 50%.<sup><xref ref-type="bibr" rid="bibr1-0269215512448256">1</xref>,<xref ref-type="bibr" rid="bibr2-0269215512448256">2</xref></sup> These arthralgias appear more commonly with aromatase inhibitor than with tamoxifen.<sup><xref ref-type="bibr" rid="bibr3-0269215512448256">3</xref><xref ref-type="bibr" rid="bibr4-0269215512448256"/>–<xref ref-type="bibr" rid="bibr5-0269215512448256">5</xref></sup> Nevertheless, a recent study has stated that arthralgia is a debilitating symptom consistently reported by a small, yet significant, proportion of tamoxifen users,<sup><xref ref-type="bibr" rid="bibr6-0269215512448256">6</xref></sup> with a profile similar to that of examestane (third generation of aromatase inhibitors) with respect to arthralgia incidence.<sup><xref ref-type="bibr" rid="bibr7-0269215512448256">7</xref></sup></p>
<p>Arthralgia is one of the most prevalent causes reducing adherence to hormone therapy in breast cancer patients.<sup><xref ref-type="bibr" rid="bibr8-0269215512448256">8</xref>,<xref ref-type="bibr" rid="bibr9-0269215512448256">9</xref></sup> Clinicians have tried a variety of interventions, though it is not clear that any of these interventions has had a dramatic effect on these symptoms.<sup><xref ref-type="bibr" rid="bibr4-0269215512448256">4</xref></sup> A possible treatment option for arthralgia may be gentle exercise. Yoga intervention has shown effectiveness in reducing pain and improving balance and flexibility in breast cancer survivors with arthralgia.<sup><xref ref-type="bibr" rid="bibr10-0269215512448256">10</xref></sup> This study was limited due to a lack of an adequate control group.</p>
<p>Aquatic exercise is a popular non-pharmacologic modality used for treating a variety of conditions, including musculoskeletal pain.<sup><xref ref-type="bibr" rid="bibr11-0269215512448256">11</xref></sup> The pain-relieving properties of hydrotherapy may be mediated by buoyancy that significantly decreases weight bearing and stress on weight-bearing joints, bones, and muscles.<sup><xref ref-type="bibr" rid="bibr12-0269215512448256">12</xref></sup> Clinical trials have found that patients with different conditions such as fibromyalgia,<sup><xref ref-type="bibr" rid="bibr13-0269215512448256">13</xref></sup> pain associated with multiple sclerosis,<sup><xref ref-type="bibr" rid="bibr14-0269215512448256">14</xref></sup> rheumatoid arthritis<sup><xref ref-type="bibr" rid="bibr15-0269215512448256">15</xref></sup> or osteoarthritis<sup><xref ref-type="bibr" rid="bibr16-0269215512448256">16</xref></sup> have less pain when hydrotherapy is used as a pain-relieving treatment. Different resources have been used, such as a deep-water pool in low back pain patients,<sup><xref ref-type="bibr" rid="bibr17-0269215512448256">17</xref></sup> but other possibilities such as a chest-high pool have not been explored previously. As research in this area is limited, we conducted a preliminary study evaluating the use of hydrotherapy to relieve hormone therapy-associated arthralgia in breast cancer survivors.</p>
<p>Obesity<sup><xref ref-type="bibr" rid="bibr5-0269215512448256">5</xref></sup> and cancer-related fatigue<sup><xref ref-type="bibr" rid="bibr18-0269215512448256">18</xref></sup> have been associated with an increased incidence of muscle pain and arthralgias in breast cancer survivors. To the best of our knowledge, there are no previous studies analysing the effectiveness of hydrotherapy in improving body composition and cancer-related fatigue, as secondary outcomes, in breast cancer survivors using hormone therapy.</p>
<p>The specific aim of this study was to investigate the impact of aquatic exercise on pressure pain threshold, cancer-related fatigue and waist circumference in breast cancer survivors suffering hormone therapy-associated arthralgia.</p>
</sec>
<sec id="section10-0269215512448256" sec-type="methods">
<title>Methods</title>
<p>The present study was a pragmatic, parallel group, controlled trial with allocation of participants into intervention (<italic>n</italic> = 20) or waiting list (<italic>n</italic> = 20, control group), according to order of arrival. Due to ethical reasons, it was not possible to randomize the patients. We had an ethical obligation with the Y010 Sport Centre to provide treatment to all patients willing to participate in the study, but due to limitations of resources we created a waiting list. For those subjects in the waiting list, data collected only during the control period were included in the current analysis. Throughout the study, all participants (including those in the control group) were encouraged to maintain their normal dietary habits. Control patients received treatment later. All patients gave informed consent for the study. This investigation was reviewed and approved by the University Hospital Virgen de las Nieves, Granada, Spain.</p>
<p>We recruited eligible patients from University Hospital Virgen de las Nieves and Hospital Clínico San Cecilio, Granada (Spain). Patients were recruited by two oncologists from the breast cancer unit. Because special facilities were required in this study (chest-high pool and complementary equipment) we contacted the Y010 Sport Club to carry out the study. Potential participants included Spanish-speaking women aged 18 years or older with stage I, II or IIIa breast cancer; and who were currently receiving aromatase inhibitors (anastrozole, letrozole or exemestane) or tamoxifen. Participants had to have had joint pain attributable to hormone therapy following previous description of this syndrome.<sup><xref ref-type="bibr" rid="bibr4-0269215512448256">4</xref></sup> Briefly, patients reported bilateral onset with symmetrical pain/soreness in their hands, knees, hips, lower back, shoulders and/or feet, with a score of at least 3 or more on an 11-point numerical rating scale<sup><xref ref-type="bibr" rid="bibr19-0269215512448256">19</xref></sup> in the preceding two weeks together with early-morning stiffness and difficulty sleeping. Exclusion criteria included metastatic breast cancer (stage IV), having completed chemotherapy or radiation therapy less than four weeks prior to enrolment, joint pain attributed to inflammatory arthritis (such as rheumatoid arthritis, osteoarthritis or gout), having severe pain or non-inflammatory arthralgia prior to hormone therapy.</p>
<p>The two-month hydrotherapy intervention consisted of 24 sessions 3 days per week. The hydrotherapy intervention was carried out in an indoor pool sized 20 × 6 m, with 140 cm water depth, 30 ± 2°C of water temperature, and 33°C of room temperature. During this session, the participants also familiarized themselves with the use of the Borg Scale, which is a simple and reliable<sup><xref ref-type="bibr" rid="bibr20-0269215512448256">20</xref></sup> method of rating perceived exertion used to control level of intensity during an exercise programme. Each aquatic therapy session lasted 60 minutes. A trainer exercise specialist and three physiotherapists supervised the participants. They were familiar with oncology exercise interventions. Each session included 5 minutes of warm-up, 15–20 minutes of aerobic exercise, 15 minutes of mobility exercise and 20 minutes of recovery techniques.</p>
<p>The aerobic exercises incorporated large muscle mass and consisted of different displacements, such as forward and backward jogging with arms pushing, pulling and pressing, leaps, leg crossovers and hopping movements focusing on travelling in multiple directions.</p>
<p>The mobility resistance exercises progressed throughout the programme by changing the number of repetitions per set (volume) and maximum range of motion without pain. Exercises were carried out at a reduced velocity and with appropriate axis orientation. Exercise included all possible joints implied in arthralgia induced by hormone therapy.</p>
<p>Participants were previously trained to relax by performing diaphragmatic breathing and concentrating on their breath. Massage techniques including superficial longitudinal strokes and local pressure over pain area were applied. Finally, full-body stretching exercises were performed at the end of each session. Participants followed usual care recommended by the oncologist in relation to a healthy lifestyle.</p>
<p>Sample size determination was performed with a software program (Tamaño de la Muestra 1.1, Madrid, Spain). The calculation was based on detecting between groups significant clinical differences of 20% on pressure pain threshold levels<sup><xref ref-type="bibr" rid="bibr21-0269215512448256">21</xref></sup> with a level of 0.05, and a desired power of 80%, and an estimated interindividual coefficient of variation for pressure pain threshold measures of 20%. This generated a sample size of at least 16 participants per group. To accommodate possible drop-outs before study completion, a total of 20 participants were included.</p>
<p>At the baseline and at the end of the eighth week, all patients were assessed for outcome variables. Pressure pain thresholds were used as the primary outcome variable as they have a reliable and adequate relationship with perceived joint pain.<sup><xref ref-type="bibr" rid="bibr21-0269215512448256">21</xref>,<xref ref-type="bibr" rid="bibr22-0269215512448256">22</xref></sup> Pressure pain threshold, defined as the minimal amount of pressure where a sensation of pressure first changes to pain,<sup><xref ref-type="bibr" rid="bibr23-0269215512448256">23</xref></sup> was assessed with an electronic algometer (Somedic AB, Farsta, Sweden). The pressure was applied at a rate of approximately 30 kPa/s with a 1-cm<sup><xref ref-type="bibr" rid="bibr2-0269215512448256">2</xref></sup> probe. Participants were instructed to press the switch when the sensation first changed from pressure to pain. The mean of three trials was calculated and used for the analysis. A 30-second resting period was allowed between each trial. The reliability of pressure algometry has been found to be high (intraclass correlation coefficient: 0.91, 95% confidence interval (CI) 0.82–0.97).<sup><xref ref-type="bibr" rid="bibr24-0269215512448256">24</xref></sup> Pressure pain threshold levels were assessed over C5–C6 zygapophyseal joints, deltoid muscles (shoulder area), second metacarpals (hand area) and tibialis anterior (leg area) muscles by an assessor blinded to the allocation of the participants.</p>
<p>Cancer-related fatigue and body composition were assessed as secondary outcomes.</p>
<p>To assess cancer-related fatigue we used the Piper Fatigue Scale following recent guidelines.<sup><xref ref-type="bibr" rid="bibr25-0269215512448256">25</xref></sup> The Piper Fatigue Scale is a validated tool assessing cancer-related fatigue, and it was selected for its particular focus on related fatigue and pain.<sup><xref ref-type="bibr" rid="bibr26-0269215512448256">26</xref></sup> The Piper Fatigue Scale is a scale with 22 numerical items assessing fatigue experienced by the patient. Using a 0–10 numerical scale, the Piper Fatigue Scale measures four dimensions of subjective fatigue: behavioural/severity, affective meaning, sensory and cognitive/mood. The total fatigue score is calculated by adding the four subscale scores and dividing this sum by 4.</p>
<p>Height (in centimetres) was measured using a stadiometer (Seca 22, Hamburg, Germany). Body mass index was calculated as weight (in kilograms) divided by height (in square metres). Waist circumference (in centimetres) was measured twice with a tape measure (Gulick; Creative Health Products, Ann Arbor, MI, USA; range 0–150 cm) at the midpoint between the lower border of the ribs and the upper border of the iliac crest. Both measurements were averaged.</p>
<sec id="section11-0269215512448256">
<title>Statistical analysis</title>
<p>Statistical analysis was performed using SPSS statistical software, version 19.0 (SPSS Inc., Chicago, IL, USA). To probe comparability of the groups, Student <italic>t</italic>-tests and chi-square tests were used to examine the differences in baseline socio-demographic and medical features between included patients. A one-way analysis of variance (ANOVA) was conducted to compare the baseline level of study variables.</p>
<p>The main analysis examined whether differences (mean differences) at baseline and eight weeks post treatment existed between hydrotherapy programme and control groups in all outcomes. A 2 × 2 mixed-model repeated-measure analysis of covariance (ANCOVA) with time (pre, post intervention) as the within-subjects variable, intervention (hydrotherapy programme, control group) as the between-subjects variable and age, civil status, educational level, type of hormone therapy, occupational status and clinical features as covariates were used to examine the effects of the intervention on the each study variable. Separate ANCOVAs were done with each outcome as dependent variable. The hypothesis of interest was intervention × time interaction. When an interaction was found, the inter-group effect size was calculated according to Cohen’s <italic>d</italic> statistic.<sup><xref ref-type="bibr" rid="bibr27-0269215512448256">27</xref></sup> An effect size &lt;0.2 reflects a negligible difference, between ≥0.2 and ≤0.5 a small difference, between ≥0.5 and ≤0.8 a moderate difference, and ≥0.8 a large difference.</p>
</sec>
</sec>
<sec id="section12-0269215512448256" sec-type="results">
<title>Results</title>
<p>Sixty-two patients were eligible for pre-screening and 40 (72.5%) were included. All patients underwent axillary lymph node dissection during the surgery. No significant differences in socio-demographic and medical features were found among the 40 patients (72.5%) included and the 22 patients (27.5%) who were excluded or declined to participate, except that a greater number of excluded/declined patients were married (12 (30%) vs. 15 (68.2 %), <italic>P</italic> &lt; 0.05)) (<xref ref-type="fig" rid="fig1-0269215512448256">Figure 1</xref>). In addition, 12 (30%) participants were taking analgesics (paracetamol) to control increased pain. No patients received any other exercise intervention during the study. There were no differences in age or clinical features between the aquatic exercise and control groups (<xref ref-type="table" rid="table1-0269215512448256">Table 1</xref>), except in employment status, with a higher proportion of non-employed in the control group than in the hydrotherapy group (11 (55%) vs. 5 (25%); <italic>P</italic> = 0.044)).</p>
<fig id="fig1-0269215512448256" position="float">
<label>Figure 1.</label>
<caption>
<p>Flow diagram of subject throughout the course of the study.</p>
</caption>
<graphic xlink:href="10.1177_0269215512448256-fig1.tif"/>
</fig>
<table-wrap id="table1-0269215512448256" position="float">
<label>Table 1.</label>
<caption>
<p>Patient characteristics and comparisons between breast cancer survivors</p>
</caption>
<graphic alternate-form-of="table1-0269215512448256" xlink:href="10.1177_0269215512448256-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Variable</th>
<th align="center">Control group (<italic>n</italic> = 20)</th>
<th align="center">Hydrotherapy programme (<italic>n</italic> = 20)</th>
<th align="center"><italic>P</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Age (years), mean (SD)</td>
<td>46.2 (7.4)</td>
<td>48.4 (10.8)</td>
<td>0.448</td>
</tr>
<tr>
<td>Time taking hormone therapy (months)</td>
<td>17.6 (6.9)</td>
<td>18.1 (8.7)</td>
<td>0.876</td>
</tr>
<tr>
<td colspan="4">Civil status, <italic>n</italic> (%)</td>
</tr>
<tr>
<td> Married</td>
<td>11 (55)</td>
<td>12 (60)</td>
<td>0.635</td>
</tr>
<tr>
<td> Unmarried</td>
<td>5 (25)</td>
<td>6 (30)</td>
<td/>
</tr>
<tr>
<td> Divorced</td>
<td>4 (20)</td>
<td>2 (10)</td>
<td/>
</tr>
<tr>
<td colspan="4">Educational level, <italic>n</italic> (%)</td>
</tr>
<tr>
<td> Low</td>
<td>7 (35)</td>
<td>4 (20)</td>
<td>0.123</td>
</tr>
<tr>
<td> Medium</td>
<td>4 (20)</td>
<td>10 (50)</td>
<td/>
</tr>
<tr>
<td> University level</td>
<td>9 (45)</td>
<td>6 (30)</td>
<td/>
</tr>
<tr>
<td colspan="4">Employment status, <italic>n</italic> (%)</td>
</tr>
<tr>
<td> Home employed</td>
<td>4 (20)</td>
<td>7 (35)</td>
<td>0.044<xref ref-type="table-fn" rid="table-fn1-0269215512448256">*</xref></td>
</tr>
<tr>
<td> Employed</td>
<td>5 (25)</td>
<td>8 (40)</td>
<td/>
</tr>
<tr>
<td> Non-employed</td>
<td>11 (55)</td>
<td>5 (25)</td>
<td/>
</tr>
<tr>
<td colspan="4">Tumour stage, <italic>n</italic> (%)</td>
</tr>
<tr>
<td> I</td>
<td>5 (25)</td>
<td>6 (30)</td>
<td>0.402</td>
</tr>
<tr>
<td> II</td>
<td>11 (55)</td>
<td>8 (40)</td>
<td/>
</tr>
<tr>
<td> IIIA</td>
<td>4 (20)</td>
<td>6 (30)</td>
<td/>
</tr>
<tr>
<td colspan="4">Type of surgery, <italic>n</italic> (%)</td>
</tr>
<tr>
<td> Tumorectomy</td>
<td>13 (65)</td>
<td>8 (40)</td>
<td>0.264</td>
</tr>
<tr>
<td> Mastectomy</td>
<td>7 (35)</td>
<td>12 (60)</td>
<td/>
</tr>
<tr>
<td colspan="4">Type of treatment <italic>n</italic> (%)</td>
</tr>
<tr>
<td> Radiation</td>
<td>0 (0)</td>
<td>2 (10)</td>
<td>0.220</td>
</tr>
<tr>
<td> Chemotherapy</td>
<td>1 (5)</td>
<td>0 (0)</td>
<td/>
</tr>
<tr>
<td> Radiation + chemotherapy</td>
<td>19 (95)</td>
<td>18 (90)</td>
<td/>
</tr>
<tr>
<td colspan="4">Hormone therapy</td>
</tr>
<tr>
<td> Tamoxifen</td>
<td>13 (65)</td>
<td>10 (50)</td>
<td>0.557</td>
</tr>
<tr>
<td colspan="4"> Aromatase inhibitors</td>
</tr>
<tr>
<td> Anastrozole</td>
<td>2 (10)</td>
<td>3 (15)</td>
<td/>
</tr>
<tr>
<td> Lestrozole</td>
<td>2 (10)</td>
<td>4 (20)</td>
<td/>
</tr>
<tr>
<td> Eximestane</td>
<td>3 (15)</td>
<td>3 (15)</td>
<td/>
</tr>
<tr>
<td colspan="4">Distribution of joint(s) pain</td>
</tr>
<tr>
<td> Knee/hip</td>
<td>4 (20)</td>
<td>6 (30)</td>
<td>0.427</td>
</tr>
<tr>
<td> Wrists/hand/elbow</td>
<td>6 (30)</td>
<td>4 (20)</td>
<td/>
</tr>
<tr>
<td> Ankle/feet</td>
<td>5 (25)</td>
<td>2 (10)</td>
<td/>
</tr>
<tr>
<td> Multi-joint diffuse</td>
<td>5 (25)</td>
<td>8 (40)</td>
<td/>
</tr>
<tr>
<td>Time after surgery treatment (months)</td>
<td>11.15 ± 3.42</td>
<td>15.25 ± 9.00</td>
<td>0.242</td>
</tr>
<tr>
<td>Body mass index (kg m<sup>−2</sup>)</td>
<td>26.33 ± 4.42</td>
<td>26.91 ± 6.99</td>
<td>0.784</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0269215512448256">
<label>*</label>
<p><italic>P</italic>-values for comparisons among group based on chi-square and analysis of variance tests.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Adherence to the intervention and adverse events were recorded in a clinical history for each participant after each session. Patients enrolled in the hydrotherapy group completed more than 79% of the 24 physical therapy treatments (mean ± SD number of sessions: 19 ± 3.7), showing a high adherence rate to the programme. Four participants in the hydrotherapy group showed a temporal (1–3 days) increase of pain after one session, but this event did not stop them continuing the programme. No further adverse events were reported.</p>
<p>In comparison to the control group, the experimental group showed a significant increase in pressure pain threshold levels over the cervical point (<italic>F</italic> = 14.462; <italic>P</italic> = 0.001), the shoulder region of the affected side (<italic>F</italic> = 4.518; <italic>P</italic> = 0.043), hand area (affected side: <italic>F</italic> = 4.282; <italic>P</italic> = 0.049; non-affected side: <italic>F</italic> = 9.918; <italic>P</italic> = 0.004) and leg area (affected side: <italic>F</italic> = 8.537; <italic>P</italic> = 0.007; non-affected side: <italic>F</italic> = 9.057; <italic>P</italic> = 0.006). There were no significant group × time × side interactions for pressure pain threshold levels over the shoulder area non-affected side (<italic>F</italic> = 3.847; <italic>P</italic> = 0.061). Neither covariate influenced the results. The hydrotherapy group experienced greater increases in pressure pain threshold levels bilaterally compared with the control group (<xref ref-type="table" rid="table2-0269215512448256">Table 2</xref>). Intergroup effect sizes were large for the cervical area (<italic>d</italic> = 1.49) unaffected hand area (<italic>d</italic> = 1.19) and leg area (affected: <italic>d</italic> = 1.30; unaffected: <italic>d</italic> = 1.15). Intergroup effect sizes were moderate for the affected shoulder area (<italic>d</italic> = 0.82) and hand area (affected: <italic>d</italic> = 0.79; unaffected: <italic>d</italic> = 0.76).</p>
<table-wrap id="table2-0269215512448256" position="float">
<label>Table 2.</label>
<caption>
<p>Pre-intervention, post-intervention and change scores for mean values of pressure pain threshold</p>
</caption>
<graphic alternate-form-of="table2-0269215512448256" xlink:href="10.1177_0269215512448256-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Group</th>
<th align="left">Control</th>
<th align="left">Hydrotherapy programme</th>
<th align="left">Between-group differences</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="4">Cervical (kPa)</td>
</tr>
<tr>
<td> Pre-intervention</td>
<td>198.99 ± 79.51</td>
<td>212.28 ± 66.65</td>
<td>−105.23 (−162.11; −48.35)<xref ref-type="table-fn" rid="table-fn3-0269215512448256">*</xref></td>
</tr>
<tr>
<td> Post-intervention</td>
<td>162.63 ± 37.99</td>
<td>281.16 ± 65.20</td>
<td/>
</tr>
<tr>
<td> Within-group change scores</td>
<td>−36.36 (−80.85; 8.12)</td>
<td>68.87 (29.33; 108.41)</td>
<td/>
</tr>
<tr>
<td colspan="4">Shoulder, affected side (kPa)</td>
</tr>
<tr>
<td> Pre-intervention</td>
<td>220.99 ± 102.61</td>
<td>233.28 ± 86.19</td>
<td>−56.05 (−110.25; −1.84) <xref ref-type="table-fn" rid="table-fn3-0269215512448256">*</xref></td>
</tr>
<tr>
<td> Post-intervention</td>
<td>219.80 ± 72.69</td>
<td>288.14 ± 58.55</td>
<td/>
</tr>
<tr>
<td> Within-group change scores</td>
<td>−1.19 (−50.92; 48.53)</td>
<td>54.85 (22.12; 87.58)</td>
<td/>
</tr>
<tr>
<td colspan="4">Shoulder, non-affected side (kPa)</td>
</tr>
<tr>
<td> Pre-intervention</td>
<td>194.21 ± 76.87</td>
<td>220.45 ± 68.42</td>
<td>– 48.82 (−99.58; 2.33)</td>
</tr>
<tr>
<td> Post-intervention</td>
<td>208.55 ± 83.16</td>
<td>283.41 ± 53.28</td>
<td/>
</tr>
<tr>
<td> Within-group change scores</td>
<td>14.33 (−32.93; 61.59)</td>
<td>62.95 (32.59; 93.32)</td>
<td/>
</tr>
<tr>
<td colspan="4">Hand, affected side (kPa)</td>
</tr>
<tr>
<td> Pre-intervention</td>
<td>241.85 ± 75.09</td>
<td>± 68.85</td>
<td>– 47.42 (−94.52; −0.31)<xref ref-type="table-fn" rid="table-fn3-0269215512448256">*</xref></td>
</tr>
<tr>
<td> Post-intervention</td>
<td>244.41 ± 58.39</td>
<td>297.85 ± 44.06</td>
<td/>
</tr>
<tr>
<td> Within-group change scores</td>
<td>2.55 (−32.37; 37.48)</td>
<td>49.97 (16.17; 83.78)</td>
<td/>
</tr>
<tr>
<td colspan="4">Hand, non-affected side (kPa)</td>
</tr>
<tr>
<td> Pre-intervention</td>
<td>±81.24</td>
<td>223.60 ± 65.84</td>
<td>−77.86 (−128.69; −27.04)<xref ref-type="table-fn" rid="table-fn3-0269215512448256">*</xref></td>
</tr>
<tr>
<td> Post-intervention</td>
<td>233.69 ± 74.62</td>
<td>283.93 ± 57.14</td>
<td/>
</tr>
<tr>
<td> Within-group change scores</td>
<td>−17.52 (−67.97; 32.92)</td>
<td>60.33 (32.94; 87.72)</td>
<td/>
</tr>
<tr>
<td colspan="4">Tibial, affected side (kPa)</td>
</tr>
<tr>
<td> Pre-intervention</td>
<td>41 ± 130.34</td>
<td>323.87 ± 63.44</td>
<td>−116.50 (−198.46; −34.54)<xref ref-type="table-fn" rid="table-fn3-0269215512448256">*</xref></td>
</tr>
<tr>
<td> Post-intervention</td>
<td>322.24 ± 97.26</td>
<td>434.20 ± 73.26</td>
<td/>
</tr>
<tr>
<td> Within-group change scores</td>
<td>−6.16 (−82.14; 69.81)</td>
<td>110.33 (61,46; 159.20)</td>
<td/>
</tr>
<tr>
<td colspan="4">Tibial, non-affected side (kPa)</td>
</tr>
<tr>
<td> Pre-intervention</td>
<td>294.52 ± 88.69</td>
<td>306.10 ± 52.82</td>
<td>−104.61 (−176.07; −33.16)<xref ref-type="table-fn" rid="table-fn3-0269215512448256">*</xref></td>
</tr>
<tr>
<td> Post-intervention</td>
<td>298.55 ± 96.60</td>
<td>414.74 ± 60.43</td>
<td/>
</tr>
<tr>
<td> Within-group change scores</td>
<td>4.02 (−61.69; 69.74)</td>
<td>108.64 (65.62; 151.66)</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0269215512448256">
<p>Values are expressed as mean ± standard deviation for pre- and post-intervention data and as mean (95% confidence interval) for within- and between-group changes.</p>
</fn>
<fn id="table-fn3-0269215512448256">
<label>*</label>
<p>Significant group × time interaction (<italic>P</italic> &lt; 0.05).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In comparison with the control group, the experimental group did not show a significant improvement in all dimensions of the Piper Fatigue Scale: affective (<italic>F</italic> = 0.829; <italic>P</italic> = 0.370), sensory (<italic>F</italic> = 1.476; <italic>P</italic> = 0.234), cognitive (<italic>F</italic> = 0.866; <italic>P</italic> = 0.360), severity (<italic>F</italic> = 0.316; <italic>P</italic> = 0.578) and total fatigue score (<italic>F</italic> = 3.806; <italic>P</italic> = 0.061) (<xref ref-type="table" rid="table3-0269215512448256">Table 3</xref>).</p>
<table-wrap id="table3-0269215512448256" position="float">
<label>Table 3.</label>
<caption>
<p>Pre-intervention, post-intervention and change scores for mean values of Piper Fatigue Scale</p>
</caption>
<graphic alternate-form-of="table3-0269215512448256" xlink:href="10.1177_0269215512448256-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Group</th>
<th align="left">Control</th>
<th align="left">Hydrotherapy programme</th>
<th align="left">Between-group differences</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="4">Behavioural/severity</td>
</tr>
<tr>
<td> Pre-intervention</td>
<td>5.82 ± 2.28</td>
<td>4.80 ± 2.19</td>
<td>0.42 (−1.12; 1.97)</td>
</tr>
<tr>
<td> Post-intervention</td>
<td>5.66 ± 1.95</td>
<td>4.21 ± 2.59</td>
<td/>
</tr>
<tr>
<td> Within-group change scores</td>
<td>−0.16 (−1.56; 1.24)</td>
<td>−0.59 (−1.43; 0.26)</td>
<td/>
</tr>
<tr>
<td colspan="4">Affective/meaning</td>
</tr>
<tr>
<td> Pre-intervention</td>
<td>6.48 ± 2.25</td>
<td>5.42 ± 2.46</td>
<td>0.64 (−0.80; 2.08)</td>
</tr>
<tr>
<td> Post-intervention</td>
<td>6.33 ± 2.27</td>
<td>4.63 ± 2.43</td>
<td/>
</tr>
<tr>
<td> Within-group change scores</td>
<td>−0.14 (−1.46; 1.17)</td>
<td>−0.79 (−1.56; 0.01)</td>
<td/>
</tr>
<tr>
<td colspan="4">Sensory</td>
</tr>
<tr>
<td> Pre-intervention</td>
<td>5.64 ± 2.44</td>
<td>4.71 ± 2.20</td>
<td>0.75 (−0.51; 2.01)</td>
</tr>
<tr>
<td> Post-intervention</td>
<td>6.11 ± 2.40</td>
<td>4.42 ± 2.39</td>
<td/>
</tr>
<tr>
<td> Within-group change scores</td>
<td>0.46 (−0.73; 1.66)</td>
<td>−0.29 (−0.90; 0.32)</td>
<td/>
</tr>
<tr>
<td colspan="4">Cognitive/mood</td>
</tr>
<tr>
<td> Pre-intervention</td>
<td>4.86 ± 2.22</td>
<td>4.52 ± 1.49</td>
<td>0.95 (−1.14; 3.04)</td>
</tr>
<tr>
<td> Post-intervention</td>
<td>5.81 ± 2.21</td>
<td>4.21± 2.25</td>
<td/>
</tr>
<tr>
<td> Within-group change scores</td>
<td>0.94 (−0.56; 2.45)</td>
<td>−0.01 (−1.58; 1.56)</td>
<td/>
</tr>
<tr>
<td colspan="4">Total fatigue score</td>
</tr>
<tr>
<td> Pre-intervention</td>
<td>5.64 ± 1.87</td>
<td>4.82 ± 1.80</td>
<td>1.08 (−0.05; 2.16)</td>
</tr>
<tr>
<td> Post-intervention</td>
<td>6.17 ± 1.94</td>
<td>4.29 ± 2.30</td>
<td/>
</tr>
<tr>
<td> Within-group change scores</td>
<td>0.55 (−0.55; 1.59)</td>
<td>−0.53 (−1.03; −0.03)</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0269215512448256">
<p>Values are expressed as mean ± standard deviation for pre- and post-intervention data and as mean (95% confidence interval) for within- and between-group changes.</p>
</fn>
<fn id="table-fn5-0269215512448256">
<label>*</label>
<p>Significant group × time interaction (<italic>P</italic> &lt; 0.05).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In comparison with the control group, the experimental group did not show a significant improvement in weight (<italic>F</italic> = 0.866; <italic>P</italic> = 0.360) and body mass index (<italic>F</italic> = 0.677; <italic>P</italic> = 0.421) (<xref ref-type="table" rid="table4-0269215512448256">Table 4</xref>). In comparison with the control group, the experimental group showed a significant change in waist circumference (<italic>F</italic> = 6.681; <italic>P</italic> = 0.014). Neither covariate influenced the results. Pair-wise comparisons revealed a non-significant increase of waist circumference in the control group (<italic>P</italic> = 0.246) compared to a decrease in the aquatic exercise group (<italic>P</italic> = 0.016). Intergroup effect size was moderate for waist circumference (<italic>d</italic> = 0.580).</p>
<table-wrap id="table4-0269215512448256" position="float">
<label>Table 4.</label>
<caption>
<p>Pre-intervention, post-intervention and change scores for mean values of body composition</p>
</caption>
<graphic alternate-form-of="table4-0269215512448256" xlink:href="10.1177_0269215512448256-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Group</th>
<th align="left">Control</th>
<th align="left">Hydrotherapy programme</th>
<th align="left">Between-group differences</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="4">Body mass index (kg m<sup>−2</sup>)</td>
</tr>
<tr>
<td> Pre-intervention</td>
<td>26.33 ± 4.42</td>
<td>26.91 ± 6.99</td>
<td>0.23 (−0.35; 0.81)</td>
</tr>
<tr>
<td> Post-intervention</td>
<td>26.66 ± 4.57</td>
<td>27.01 ± 7.28</td>
<td/>
</tr>
<tr>
<td> Within-group change scores</td>
<td>0.33 (−0.06; 0.73)</td>
<td>0.10 (−0.36; 0.55)</td>
<td/>
</tr>
<tr>
<td colspan="4">Waist circumference (cm)</td>
</tr>
<tr>
<td> Pre-intervention</td>
<td>86.96 ± 8.79</td>
<td>92.37 ± 19.30</td>
<td>3.70 (0.78; 6.62)<xref ref-type="table-fn" rid="table-fn7-0269215512448256">*</xref></td>
</tr>
<tr>
<td> Post-intervention</td>
<td>87.68 ± 9.49</td>
<td>89.39 ± 18.83</td>
<td/>
</tr>
<tr>
<td> Within-group change scores</td>
<td>0.72 (−0.56; 2,11)</td>
<td>−2.98 (−5.39; −0.56)</td>
<td/>
</tr>
<tr>
<td colspan="4">Weight (kg)</td>
</tr>
<tr>
<td> Pre-intervention</td>
<td>68.86 ± 10.99</td>
<td>69.97 ± 18.69</td>
<td>0.61 (−0.71; 1.93)</td>
</tr>
<tr>
<td> Post-intervention</td>
<td>69.61 ± 11.23</td>
<td>70.11 ± 19.17</td>
<td/>
</tr>
<tr>
<td> Within-group change scores</td>
<td>0.75 (−0.16; 1.66)</td>
<td>0.14 (−0.88; 1.17)</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-0269215512448256">
<p>Values are expressed as mean ± standard deviation for pre- and post-intervention data and as mean (95% confidence interval) for within- and between-group changes.</p>
</fn>
<fn id="table-fn7-0269215512448256">
<label>*</label>
<p>Significant group × time interaction (<italic>P</italic> &lt; 0.05).</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section13-0269215512448256" sec-type="discussion">
<title>Discussion</title>
<p>This study confirms that breast cancer survivors with hormone therapy-associated arthralgia demonstrate an improvement in pressure pain threshold and a reduction of waist circumference after eight weeks of hydrotherapy intervention. In addition, a hydrotherapy intervention was well tolerated, with minimal side-effects. No significant benefits were observed in cancer-related fatigue.</p>
<p>To avoid interference with the efficacy of the drug, relief of hormone therapy-associated arthralgia through non-pharmacological strategies is welcomed. We did not find any influence of the type of hormone therapy (tamoxifen vs. aromatase inhibitors) in the analgesic effects of hydrotherapy found in this study. The origin of the arthralgias induced by aromatase inhibitors and tamoxifen is not well known but could be different.<sup><xref ref-type="bibr" rid="bibr4-0269215512448256">4</xref>,<xref ref-type="bibr" rid="bibr6-0269215512448256">6</xref></sup> Possible mechanisms of the analgesic effects of hydrotherapy are well known; the hydrostatic effect of water can alleviate pain by reducing peripheral oedema and sympathetic nervous system activity.<sup><xref ref-type="bibr" rid="bibr28-0269215512448256">28</xref>,<xref ref-type="bibr" rid="bibr29-0269215512448256">29</xref></sup> In addition, we used warm-water spa facilities in our study. This can block nociceptors by acting on thermal receptors and mechanoreceptors and exert a positive effect on spinal segmental mechanisms.<sup><xref ref-type="bibr" rid="bibr30-0269215512448256">30</xref></sup> Pressure algometry cannot tell us whether the reduced pain perception in this study is the result of changes in neuronal excitability or local muscle/joint response, but we can say that the improvement in sensitization process is not influenced by psychological features of the person or mediated by social aspects.<sup><xref ref-type="bibr" rid="bibr31-0269215512448256">31</xref></sup></p>
<p>The aquatic exercise programme used in this study failed to improve cancer-related fatigue with respect to usual care. These results are not unexpected, the exercise proposed in this study was focused on the analgesic effect using different mobility exercises combined with stretching and massage procedures. Only 25% of the total time was dedicated to improving the endurance of the patients. It is known that in order to reduce cancer-related fatigue, a large amount of aerobic exercise<sup><xref ref-type="bibr" rid="bibr32-0269215512448256">32</xref></sup> and moderate resistance programme<sup><xref ref-type="bibr" rid="bibr33-0269215512448256">33</xref></sup> are needed.</p>
<p>An interesting finding of this study was the reduction in waist circumference in the hydrotherapy group compared with the control group. These results help to reinforce the evidence level regarding the ability of exercise interventions to reduce waist circumference.<sup><xref ref-type="bibr" rid="bibr34-0269215512448256">34</xref></sup> However, the intervention failed to improve body size similarly to previous research.<sup><xref ref-type="bibr" rid="bibr35-0269215512448256">35</xref>,<xref ref-type="bibr" rid="bibr36-0269215512448256">36</xref></sup> The increase of physical activity level in the intervention group with respect to the control group ranged from approximately 10.2 MET to 12.2 MET per week.<sup><xref ref-type="bibr" rid="bibr37-0269215512448256">37</xref>,<xref ref-type="bibr" rid="bibr38-0269215512448256">38</xref></sup> This increase in physical activity level associated with a water environment favourable to high levels of energy expenditure with relatively little strain to the body<sup><xref ref-type="bibr" rid="bibr39-0269215512448256">39</xref></sup> could promote the change in waist circumference found in our sample of breast cancer survivors.</p>
<p>The limitations of our single-institution study were its relatively small sample size and possible selection bias introduced by those who agree to participate in this type of study given the time requirements. In addition, the fact that this was a pragmatic design without randomization process could be considered a limitation of this study, although the observation that there was no significant difference in baseline measurement attenuated the influence of this limitation. The most common approach to pain measurement is through patient self-report scales. These scales include physiological and psychological components that could be difficult to interpret. We decided to assess pressure pain threshold to give a more focused measurement in pain perception. Finally, there are no follow-up data, which could generate doubts about whether the benefit of this programme is sustained.</p>
<p>In conclusion, this report is the first controlled trial establishing the use of hydrotherapy to improve hormone therapy-associated arthralgia. It should be confirmed in a larger randomized trial. Probably in the next years, arthralgia could be a major issue for breast cancer survivors with long-term use of hormone therapy. This study suggests that hydrotherapy could help to attenuate joint pain and improve body composition in breast cancer survivors.</p>
<boxed-text id="boxed-text1-0269215512448256" position="float">
<title>Clinical messages</title>
<list id="list1-0269215512448256" list-type="bullet">
<list-item>
<p>Eight weeks of aquatic exercise programme in breast cancer survivors with hormone therapy-induced arthralgia reduce pain threshold.</p>
</list-item>
<list-item>
<p>Aquatic exercise can contribute to a reduction in waist circumference. However, a programme of 24 treatment sessions carried out in a chest-high pool does not produce significant improvement in cancer-related fatigue, weight or body mass index.</p>
</list-item>
</list>
</boxed-text>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>We gratefully acknowledge all participating patients for their collaboration. The study was funded by a research project grant (FIS PI10/02749-02764) from the Health Institute Carlos III and PN I+D+I 2008-2011, a grant (Program FPU AP2010-6075) from Education Ministry, Madrid, Spanish Government and a grant of Andalusian Health Service, Junta de Andalucia (PI-0457-2010).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0269215512448256">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Howell</surname><given-names>A</given-names></name>
<name><surname>Cuzick</surname><given-names>J</given-names></name>
<name><surname>Baum</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Results of the ATAC (arimidex, tamoxifen, alone or in combination) trial after completion of 5 years’ adjuvant treatment for breast cancer</article-title>. <source>Lancet</source> <year>2005</year>; <volume>365</volume>: <fpage>60</fpage>–<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr2-0269215512448256">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mao</surname><given-names>JJ</given-names></name>
<name><surname>Stricker</surname><given-names>C</given-names></name>
<name><surname>Bruner</surname><given-names>D</given-names></name>
<etal/>
</person-group>. <article-title>Patterns and risk factors associated with aromatase inhibitor related arthralgia among breast cancer survivors</article-title>. <source>Cancer</source> <year>2009</year>; <volume>115</volume>: <fpage>3631</fpage>–<lpage>3639</lpage>.</citation>
</ref>
<ref id="bibr3-0269215512448256">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cuzick</surname><given-names>J</given-names></name>
<name><surname>Sestak</surname><given-names>I</given-names></name>
<name><surname>Baum</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>ATAC/LATTE investigators. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial</article-title>. <source>Lancet Oncol</source> <year>2010</year>; <volume>11</volume>: <fpage>1135</fpage>–<lpage>1141</lpage>.</citation>
</ref>
<ref id="bibr4-0269215512448256">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Burstein</surname><given-names>HJ</given-names></name>
</person-group>. <article-title>Aromatase inhibitor-associated arthralgia syndrome</article-title>. <source>Breast</source> <year>2007</year>; <volume>16</volume>: <fpage>223</fpage>–<lpage>234</lpage>.</citation>
</ref>
<ref id="bibr5-0269215512448256">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sestak</surname><given-names>I</given-names></name>
<name><surname>Cuzick</surname><given-names>J</given-names></name>
<name><surname>Sapunar</surname><given-names>F</given-names></name>
<etal/>
</person-group>. <article-title>ATAC Trialists’ Group. Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis</article-title>. <source>Lancet Oncol</source> <year>2008</year>; <volume>9</volume>: <fpage>866</fpage>–<lpage>872</lpage>.</citation>
</ref>
<ref id="bibr6-0269215512448256">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blencowe</surname><given-names>NS</given-names></name>
<name><surname>Reichl</surname><given-names>C</given-names></name>
<name><surname>Gahir</surname><given-names>J</given-names></name>
<name><surname>Paterson</surname><given-names>I</given-names></name>
</person-group>. <article-title>The use of Nolvadex in the treatment of generic tamoxifen-associated small joint arthralgia</article-title>. <source>Breast</source> <year>2010</year>; <volume>19</volume>: <fpage>243</fpage>–<lpage>245</lpage>.</citation>
</ref>
<ref id="bibr7-0269215512448256">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kittaneh</surname><given-names>M</given-names></name>
<name><surname>Glück</surname><given-names>S</given-names></name>
</person-group>. <article-title>Exemestane in the adjuvant treatment of breast cancer in postmenopausal women</article-title>. <source>Breast Cancer (Auckl)</source> <year>2011</year>; <volume>5</volume>: <fpage>209</fpage>–<lpage>226</lpage>.</citation>
</ref>
<ref id="bibr8-0269215512448256">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harbeck</surname><given-names>N</given-names></name>
<name><surname>Haidinger</surname><given-names>R</given-names></name>
</person-group>. <article-title>The patient experience</article-title>. <source>Breast Cancer Res Treat</source> <year>2007</year>; <volume>105</volume>: <fpage>91</fpage>–<lpage>e103</lpage>.</citation>
</ref>
<ref id="bibr9-0269215512448256">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Crew</surname><given-names>KD</given-names></name>
<name><surname>Capodice</surname><given-names>JL</given-names></name>
<name><surname>Greenlee</surname><given-names>H</given-names></name>
<etal/>
</person-group>. <article-title>Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer</article-title>. <source>J Clin Oncol</source> <year>2010</year>; <volume>28</volume>: <fpage>1154</fpage>–<lpage>1160</lpage>.</citation>
</ref>
<ref id="bibr10-0269215512448256">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Galantino</surname><given-names>ML</given-names></name>
<name><surname>Dasei</surname><given-names>K</given-names></name>
<name><surname>Greene</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>Impact of yoga on functional outcomes in breast cancer survivors with aromatase inhibitor-associated arthalgias</article-title>. <source>Integr Cancer Ther</source> <year>2011</year>; <fpage>6</fpage>.</citation>
</ref>
<ref id="bibr11-0269215512448256">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cuesta-Vargas</surname><given-names>AI</given-names></name>
<name><surname>García-Romero</surname><given-names>JC</given-names></name>
<name><surname>Arroyo-Morales</surname><given-names>M</given-names></name>
<name><surname>Diego-Acosta</surname><given-names>AM</given-names></name>
<name><surname>Daly</surname><given-names>DJ</given-names></name>
</person-group>. <article-title>Exercise, manual therapy, and education with or without high-intensity deep-water running for nonspecific chronic low back pain: a pragmatic randomized controlled trial</article-title>. <source>Am J Phys Med Rehabil</source> <year>2011</year>; <volume>90</volume>: <fpage>526</fpage>–<lpage>534</lpage>.</citation>
</ref>
<ref id="bibr12-0269215512448256">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Waller</surname><given-names>B</given-names></name>
<name><surname>Lambeck</surname><given-names>J</given-names></name>
<name><surname>Daly</surname><given-names>D</given-names></name>
</person-group>. <article-title>Therapeutic aquatic exercise in the treatment of low back pain: a systematic review</article-title>. <source>Clin Rehabil</source> <year>2009</year>; <volume>23</volume>: <fpage>3</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr13-0269215512448256">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>De Andrade</surname><given-names>SC</given-names></name>
<name><surname>de Carvalho</surname><given-names>RF</given-names></name>
<name><surname>Soares</surname><given-names>AS</given-names></name>
<etal/>
</person-group>. <article-title>Talassotherapy for fibromyalgia: a randomized controlled trial comparing aquatic exercises in sea water and water pool</article-title>. <source>Rheumatol Int</source> <year>2008</year>; <volume>29</volume>: <fpage>147</fpage>–<lpage>152</lpage>.</citation>
</ref>
<ref id="bibr14-0269215512448256">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Castro-Sánchez</surname><given-names>AM</given-names></name>
<name><surname>Matarán-Peñarrocha</surname><given-names>GA</given-names></name>
<name><surname>Lara-Palomo</surname><given-names>I</given-names></name>
<name><surname>Saavedra-Hernández</surname><given-names>M</given-names></name>
<name><surname>Arroyo-Morales</surname><given-names>M</given-names></name>
<name><surname>Moreno-Lorenzo</surname><given-names>C</given-names></name>
</person-group>. <article-title>Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial</article-title>. <source>Evid Based Complement Alternat Med</source> <year>2012</year>; <fpage>473963</fpage>.</citation>
</ref>
<ref id="bibr15-0269215512448256">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ahern</surname><given-names>M</given-names></name>
<name><surname>Nicholis</surname><given-names>E</given-names></name>
<name><surname>Simionato</surname><given-names>E</given-names></name>
<name><surname>Clark</surname><given-names>M</given-names></name>
<name><surname>Bond</surname><given-names>M</given-names></name>
</person-group>. <article-title>Clinical and psychological effects of hydrotherapy in rheumatic diseases</article-title>. <source>Clin Rehabil</source> <year>1995</year>; <volume>9</volume>: <fpage>204</fpage>–<lpage>212</lpage>.</citation>
</ref>
<ref id="bibr16-0269215512448256">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lin</surname><given-names>SYC</given-names></name>
<name><surname>Davey</surname><given-names>RC</given-names></name>
<name><surname>Cochrane</surname><given-names>T</given-names></name>
</person-group>. <article-title>Community rehabilitation for older adults with osteoarthritis of the lower limb: a controlled clinical trial</article-title>. <source>Clin Rehabil</source> <year>2004</year>; <volume>18</volume>: <fpage>92</fpage>–<lpage>101</lpage>.</citation>
</ref>
<ref id="bibr17-0269215512448256">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cuesta-Vargas</surname><given-names>AI</given-names></name>
<name><surname>Adams</surname><given-names>N</given-names></name>
<name><surname>Salazar</surname><given-names>JA</given-names></name>
<name><surname>Belles</surname><given-names>A</given-names></name>
<name><surname>Hazañas</surname><given-names>S</given-names></name>
<name><surname>Arroyo-Morales</surname><given-names>M</given-names></name>
</person-group>. <article-title>Deep water running and general practice in primary care for non-specific low back pain versus general practice alone: randomized controlled trial</article-title>. <source>Clin Rheumatol</source> <year>2012</year>; Mar <fpage>29</fpage>.</citation>
</ref>
<ref id="bibr18-0269215512448256">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cantarero-Villanueva</surname><given-names>I</given-names></name>
<name><surname>Fernández-Lao</surname><given-names>C</given-names></name>
<name><surname>Fernández-de-Las-Peñas</surname><given-names>C</given-names></name><etal/>
</person-group>. <article-title>Associations among musculoskeletal impairments, depression, body image and fatigue in breast cancer survivors within the first year after treatment</article-title>. <source>Eur J Cancer Care (Engl)</source> <year>2011</year>; <volume>20</volume>: <fpage>632</fpage>–<lpage>639</lpage>.</citation>
</ref>
<ref id="bibr19-0269215512448256">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Katz</surname><given-names>R</given-names></name>
<name><surname>Melzack</surname><given-names>R</given-names></name>
</person-group>. <article-title>Measurement of pain</article-title>. <source>Surg Clin North Am</source> <year>1999</year>; <volume>79</volume>: <fpage>231</fpage>–<lpage>252</lpage>.</citation>
</ref>
<ref id="bibr20-0269215512448256">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Doherty</surname><given-names>M</given-names></name>
<name><surname>Smith</surname><given-names>PM</given-names></name>
<name><surname>Hughes</surname><given-names>MG</given-names></name>
<name><surname>Collins</surname><given-names>D</given-names></name>
</person-group>. <article-title>Rating of perceived exertion duringhigh-intensity treadmill running</article-title>. <source>Med Sci Sports Exerc</source> <year>2001</year>; <volume>33</volume>: <fpage>1953</fpage>–<lpage>1958</lpage>.</citation>
</ref>
<ref id="bibr21-0269215512448256">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wylde</surname><given-names>V</given-names></name>
<name><surname>Palmer</surname><given-names>S</given-names></name>
<name><surname>Learmonth</surname><given-names>ID</given-names></name>
<name><surname>Dieppe</surname><given-names>P</given-names></name>
</person-group>. <article-title>Test-retest reliability of Quantitative Sensory Testing in knee osteoarthritis and healthy participants</article-title>. <source>Osteoarthritis Cartilage</source> <year>2011</year>; <volume>19</volume>: <fpage>655</fpage>–<lpage>682</lpage>.</citation>
</ref>
<ref id="bibr22-0269215512448256">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arendt-Nielsen</surname><given-names>L</given-names></name>
<name><surname>Nie</surname><given-names>H</given-names></name>
<name><surname>Laursen</surname><given-names>MB</given-names></name>
<etal/>
</person-group>. <article-title>Sensitization in patients with painful knee osteoarthritis</article-title>. <source>Pain</source> <year>2010</year>; <volume>149</volume>: <fpage>573</fpage>–<lpage>581</lpage>.</citation>
</ref>
<ref id="bibr23-0269215512448256">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Prushansky</surname><given-names>T</given-names></name>
<name><surname>Dvir</surname><given-names>Z</given-names></name>
<name><surname>Defron-Assa</surname><given-names>R</given-names></name>
</person-group>. <article-title>Reproducibility indices applied to cervical pressure pain threshold measurements in healthy subjects</article-title>. <source>Clin J Pain</source> <year>2004</year>; <volume>20</volume>: <fpage>341</fpage>–<lpage>347</lpage>.</citation>
</ref>
<ref id="bibr24-0269215512448256">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chesterson</surname><given-names>LS</given-names></name>
<name><surname>Sim</surname><given-names>J</given-names></name>
<name><surname>Wright</surname><given-names>CC</given-names></name>
<etal/>
</person-group>. <article-title>Inter-rater reliability of algometry in measuring pressure pain thresholds in healthy humans, using multiple raters</article-title>. <source>Clin J Pain</source> <year>2007</year>; <volume>23</volume>: <fpage>760</fpage>–<lpage>766</lpage>.</citation>
</ref>
<ref id="bibr25-0269215512448256">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barsevick</surname><given-names>AM</given-names></name>
<name><surname>Cleeland</surname><given-names>CS</given-names></name>
<name><surname>Manning</surname><given-names>DC</given-names></name>
<etal/>
</person-group>. <article-title>ASCPRO (Assessing Symptoms of Cancer Using Patient-Reported Outcomes). ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials</article-title>. <source>J Pain Symptom Manage</source> <year>2010</year>; <volume>39</volume>: <fpage>1086</fpage>–<lpage>1099</lpage>.</citation>
</ref>
<ref id="bibr26-0269215512448256">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Giacalone</surname><given-names>A</given-names></name>
<name><surname>Polesel</surname><given-names>J</given-names></name>
<name><surname>De Paoli</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>Assessing cancer-related fatigue: the psychometric properties of the Revised Piper Fatigue Scale in Italian cancer inpatients</article-title>. <source>Support Care Cancer</source> <year>2010</year>; <volume>18</volume>: <fpage>1191</fpage>–<lpage>1197</lpage>.</citation>
</ref>
<ref id="bibr27-0269215512448256">
<label>27.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Cohen</surname><given-names>J</given-names></name>
</person-group>. <source>Statistical power analysis for the behavioral sciences</source>. <publisher-loc>Hillsdale, NJ</publisher-loc>: <publisher-name>Lawrence Erlbaum Associates</publisher-name>, <year>1998</year>.</citation>
</ref>
<ref id="bibr28-0269215512448256">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kamioka</surname><given-names>H</given-names></name>
<name><surname>Tsutani</surname><given-names>K</given-names></name>
<name><surname>Okuizumi</surname><given-names>H</given-names></name>
<etal/>
</person-group>. <article-title>Effectiveness of aquatic exercise and balneotherapy: a summary of systematic reviews based on randomized controlled trials of water immersion therapies</article-title>. <source>J Epidemiol</source> <year>2010</year>; <volume>20</volume>: <fpage>2</fpage>–<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr29-0269215512448256">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gabrielsen</surname><given-names>A</given-names></name>
<name><surname>Videbek</surname><given-names>R</given-names></name>
<name><surname>Johansen</surname><given-names>LB</given-names></name>
<etal/>
</person-group>. <article-title>Forearm vascular and neuroendocrine responses to graded water immersion in humans</article-title> <source>Acta Physiol Scand</source> <year>2000</year>; <volume>169</volume>: <fpage>87</fpage>–<lpage>94</lpage>.</citation>
</ref>
<ref id="bibr30-0269215512448256">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bender</surname><given-names>T</given-names></name>
<name><surname>Karagülle</surname><given-names>Z</given-names></name>
<name><surname>Bálint</surname><given-names>GP</given-names></name>
<etal/>
</person-group>. <article-title>Hydrotherapy, balneotherapy, and spa treatment in pain management</article-title>. <source>Rheumatol Int</source> <year>2005</year>; <volume>25</volume>: <fpage>220</fpage>–<lpage>224</lpage>.</citation>
</ref>
<ref id="bibr31-0269215512448256">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Walton</surname><given-names>DM</given-names></name>
<name><surname>Macdermid</surname><given-names>JC</given-names></name>
<name><surname>Nielson</surname><given-names>W</given-names></name>
<name><surname>Teasell</surname><given-names>RW</given-names></name>
<name><surname>Chialsson</surname><given-names>M</given-names></name>
<name><surname>Brown</surname><given-names>L</given-names></name>
</person-group>. <article-title>Reliability, standard error and minimum detectable change of clinical pressure pain threshold testing in people with and without acute neck pain</article-title>. <source>J Orthop Sports Phys Ther</source> <year>2011</year>; <volume>41</volume>: <fpage>644</fpage>–<lpage>650</lpage>.</citation>
</ref>
<ref id="bibr32-0269215512448256">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McMillan</surname><given-names>EM</given-names></name>
<name><surname>Newhouse</surname><given-names>IJ</given-names></name>
</person-group>. <article-title>Exercise is an effective treatment modality for reducing cancer-related fatigue and improving physical capacity in cancer patients and survivors: a meta-analysis</article-title>. <source>Appl Physiol Nutr Metab</source> <year>2011</year>; <volume>36</volume>: <fpage>892</fpage>–<lpage>903</lpage>.</citation>
</ref>
<ref id="bibr33-0269215512448256">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brown</surname><given-names>JC</given-names></name>
<name><surname>Huedo-Medina</surname><given-names>TB</given-names></name>
<name><surname>Pescatello</surname><given-names>LS</given-names></name>
<etal/>
</person-group>. <article-title>Efficacy of exercise interventions in modulating cancer-related fatigue among adult cancer survivors: a meta-analysis</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <year>2011</year>; <volume>20</volume>: <fpage>123</fpage>–<lpage>133</lpage>.</citation>
</ref>
<ref id="bibr34-0269215512448256">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schmitz</surname><given-names>KH</given-names></name>
<name><surname>Courneya</surname><given-names>KS</given-names></name>
<name><surname>Matthews</surname><given-names>C</given-names></name>
<etal/>
</person-group>.; <collab>American College of Sports Medicine</collab>. <article-title>American College of Sports Medicine roundtable on exercise guidelines for cancer survivors</article-title>. <source>Med Sci Sports Exerc</source> <year>2010</year>; <volume>42</volume>: <fpage>1409</fpage>–<lpage>1426</lpage>.</citation>
</ref>
<ref id="bibr35-0269215512448256">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Battaglini</surname><given-names>CL</given-names></name>
<name><surname>Mihalik</surname><given-names>JP</given-names></name>
<name><surname>Bottaro</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>Effect of exercise on the caloric intake of breast cancer patients undergoing treatment</article-title>. <source>Braz J Med Biol Res</source> <year>2008</year>; <volume>41</volume>: <fpage>709</fpage>–<lpage>715</lpage>.</citation>
</ref>
<ref id="bibr36-0269215512448256">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Demark-Wahnefried</surname><given-names>W</given-names></name>
<name><surname>Case</surname><given-names>LD</given-names></name>
<name><surname>Blackwell</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>Results of a diet/exercise feasibility trial to prevent adverse body composition change in breast cancer patients on adjuvant chemotherapy</article-title>. <source>Clin Breast Cancer</source> <year>2008</year>; <volume>8</volume>: <fpage>70</fpage>–<lpage>79</lpage>.</citation>
</ref>
<ref id="bibr37-0269215512448256">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hered</surname><given-names>SL</given-names></name>
<name><surname>Darby</surname><given-names>LA</given-names></name>
<name><surname>Yaekle</surname><given-names>GC</given-names></name>
</person-group>. <article-title>Comparison of physiological responses to comparable land and water exercises</article-title>. <source>Med Sci Exerc Sport</source> <year>1997</year>; <volume>29</volume>: <fpage>S162</fpage>.</citation>
</ref>
<ref id="bibr38-0269215512448256">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kirby</surname><given-names>RL</given-names></name>
<name><surname>Sacamano</surname><given-names>JT</given-names></name>
<name><surname>Balch</surname><given-names>DE</given-names></name>
<name><surname>Kriellaars</surname><given-names>DJ</given-names></name>
</person-group>. <article-title>Oxygen consumption during exercise in a heated pool</article-title>. <source>Arch Phys Med Rehabil</source> <year>1984</year>; <volume>65</volume>: <fpage>21</fpage>–<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr39-0269215512448256">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Di Prampero</surname><given-names>PE</given-names></name>
</person-group>. <article-title>The energy cost of human locomotion on land and in water</article-title>. <source>Int J Sports Med</source> <year>1986</year>; <volume>7</volume>: <fpage>55</fpage>–<lpage>72</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>